Option traders appear to be setting up for a bullish move on Janus Capital Group (JNS). Traders plowed into 1,010 new call option contracts -- 7.77 times the average volume -- on the stock on Friday. And we know that traders were eager to get into this trade because 99% of the trades came in on the ask price.

Janus Capital closed Thursday at $9.51. The stock has dropped 9.86% during the past month and is currently sitting above support at $9.

MOST NOTEWORTHY: Amag Pharmaceuticals, Corn Products and Alpharma were today's noteworthy initiations:

• Baird initiated Amag Pharmaceuticals (NASDAQ: AMAG) with an Outperform rating and believes concerns regarding ferumoxytol approvability are misplaced.
• JP Morgan assumed coverage of Corn Products (NYSE: CPO) with an Overweight rating and points to the company's growth in emerging markets and improved business economics in its core U.S. market.
• RBC Capital is positive on Alpharma's (NYSE: ALO) Flector opportunity in the U.S. topical NSAID market. The firm started shares with an Outperform rating and $28 target.

OTHER INITIATIONS:

• Merrill resumed coverage of Baxter (NYSE: BAX) with a Buy rating.
• Goldman initiated Teradyne (NYSE: TER) with a Neutral rating and $11 target.
• Allianz AG (NYSE: AZ) was initiated with a Buy rating at Societe Generale.